Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Richard O'Dwyer"'
Autor:
Geoffrey Alan Watson, Richard O'Dwyer, Razia Aslam, Sue Sukor, Oana Deac, John G. Kennedy, Antonia Tierney
Publikováno v:
Clinical Breast Cancer. 19:e186-e194
Background The cyclin-dependent kinase 4/6 inhibitor palbociclib has emerged as a novel therapeutic agent in metastatic breast cancer. Neutropenia is commonly observed, and thus stringent treatment guidelines regarding complete blood count (CBC) moni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38d6a4b737a81706ee5ab95333523f1e
https://doi.org/10.1016/j.clbc.2018.09.002
https://doi.org/10.1016/j.clbc.2018.09.002
Autor:
Lisa Mary Prior, Megan Greally, Patrick G. Morris, Jack Patrick Gleeson, David O'Reilly, Hazel Murray, Rajnish Gupta, Jennifer Westrup, Janice M. Walshe, Razia Aslam, Paul M Walsh, Emmet Jordan, Seamus O'Reilly, M. Higgins, Richard O'Dwyer, Anees Hassan, Deirdre Kelly, Lisa Kiely, Nada Ahmed, Liam Grogan, Marvin Lim, Alfred Ndahi Jones, Linda Coate, John Crown, Elaine M. Walsh, Lillian Smyth, K Duffy, M. John Kennedy, G. Leonard, Oscar S. Breathnach, Paula Calvert, Elly Hanis Che Othman, Abdul R Farooq, Catherine M. Kelly, Giuseppe Gullo, John McCaffrey, Geoffrey Watson, Waseem Darwish, Cian Ward, Connor O'Leary, Miriam O'Connor, Deirdre O'Mahony, Anne M. Horgan, Bryan T. Hennessy, Hannah Featherstone, Desmond N. Carney, M. Keane
Publikováno v:
Breast cancer research and treatment. 189(1)
Pregnancy-associated breast cancer (PABC) is defined as breast cancer diagnosed during the gestational period (gp-PABC) or in the first postpartum year (pp-PABC). Despite its infrequent occurrence, the incidence of PABC appears to be rising due to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d50a148efab3979afa98e6c0e23860c
https://pubmed.ncbi.nlm.nih.gov/34125341
https://pubmed.ncbi.nlm.nih.gov/34125341
Publikováno v:
Journal of Clinical Oncology. 36:e13061-e13061
e13061Background: Palbociclib is a novel small molecule inhibitor of cyclin dependant kinases 4 and 6, and has been shown to improve progression free survival in HR positive metastatic breast cance...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ae54eae6b53d4d80afe377a2dc40435
https://doi.org/10.1200/jco.2018.36.15_suppl.e13061
https://doi.org/10.1200/jco.2018.36.15_suppl.e13061